To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

J&J sold artificial hip in UK that US rejected

By Barry Meier

 |  New York times  

  February 15, 2012

The health care products giant Johnson & Johnson continued to market an artificial hip in Europe and elsewhere overseas for a year after the Food and Drug Administration rejected its sale in the United States based on a review of company safety studies. During that same period, the company also continued to sell a related model in this country, which earlier went on the market using a regulatory loophole that did not require a similar safety review.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help